獸醫腫瘤學市場:各動物類型，各治療類型，劑型，各用途，各流通管道，各地區- 規模，佔有率，展望，機會分析，2022年～2030年

市場動態

市場參與者擴大採用無機增長戰略，如研發計劃和夥伴關係，如獸醫癌症治療宣傳活動，預計將在預測期內推動市場增長。

本調查的主要特徵

• 本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球獸醫腫瘤學市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
• 並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
• 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
• 並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球獸醫腫瘤學市場的主要參與者之企業簡介。
• 藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 全球獸醫腫瘤學市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以透過全球獸醫腫瘤學市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查目的與前提條件

• 調查目的
• 前提條件
• 簡稱的說明

第2章 市場展望

• 報告內容
  • 市場定義和範圍
• 摘要整理
  • 市場概述:各動物類型
  • 市場概述:各治療類型
  • 市場概述:給藥模式別
  • 市場概述:各應用領域
  • 市場概述:各流通管道
  • 市場概述:各地區
• 連貫機遇地圖(COM)

第3章 市場動態，法規，趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會
• 影響分析
• 獸醫學的腫瘤的預防和控制的配合措施
• 放射線治療
• 市場趨勢
• 產品回收
• 流行病學
• 主要的發展情形
• 貓的癌症
• 狗的癌症
• 動物用醫藥品常使用的化療劑
• 法規方案
• 動物用醫藥品專利資訊
• 動物用癌症啟發活動
• M&A(合併·收購
• PEST分析

第4章 獸醫腫瘤學的全球市場-冠狀病毒(COVID-19)疫情的影響

• 整體影響
• 政府的配合措施
• COVID-19市場的影響

第5章 獸醫腫瘤學的全球市場，各動物類型，2017年～2030年

• 寵物
• 市場規模·預測·YoY成長率，2017年～2030年
• 市場規模，預測，與前一年同期比較成長率，2017年～2030年
• 市場規模，預測，與前一年同期比較成長率，2017-2030年
• 畜產動物

第6章 獸醫腫瘤學的全球市場(各治療類型):2017年～2030年

• 化療
• 聯合治療
• 免疫療法
• 標靶治療

第7章 獸醫腫瘤學的全球市場，劑型，2017年～2030年

• 口服給藥
• 靜脈注射

第8章 獸醫腫瘤學的全球市場:各用途，2017年～2030年

• 狗淋巴瘤
• 骨癌(OSA)
• 肥胖細胞腫(Mast Cell Cancer
• 黑色素瘤
• 多發性骨髓瘤

第9章 獸醫腫瘤學的全球市場(各流通管道):2017年～2030年

• 醫院藥局
• 政府機關
• 零售藥局

第10章 獸醫腫瘤學的全球市場:各地區，2017年～2030年

• 北美
• 美國
• 加拿大
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他的南美地區
• 歐洲
• 英國
• 德國
• 義大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 印度
• 日本
• ASEAN
• 澳洲
• 韓國
• 其他亞太地區
• 中東地區
• GCC
• 以色列
• 其他的中東地區
• 非洲
• 北非
• 中非
• 南非

第11章 競爭情形

• 企業簡介
  • Zoetis Inc.
  • Elanco
  • AB Science
  • Boehringer Ingelheim International GmbH
  • Zenoaq
  • VetDC
  • Morphogenesis, Inc.
  • Karyopharm Therapeutics, Inc.
  • Regeneus Ltd.
  • AdvaVet, Inc.
  • Rhizen Pharmaceutical SA

第12章 章節

• 參考文獻
• 調查手法的介紹
• 關於出版社

Veterinary oncology is subspecialty of veterinary medicine that deals with the diagnosis and treatment of cancer in animals. With emerging technologies, the use of biotechnology products in veterinary medicines is increasing. Despite the costs that many times accompany the development of novel biotechnological products, recombinant virus vector vaccines, recombinant proteins such as bioactive cytokines and immunotherapeutic allergens, therapeutic antibodies, and oncolytic viruses are the result of advancements in biotechnology for veterinary medicines. The benefits associated with using biotechnology products are large-scale production, reduced costs, long-term action, and multiple antigen vaccines. A veterinary oncologist has specialized knowledge in the diagnosis of cancer, the staging of tumors, the development of treatment plans, and the administration of chemotherapy. Veterinary oncologists determine the most appropriate course of treatment and coordinate the treatment program for pets with cancer. They also frequently serve as consultants to veterinarians in private practice to ensure that their patients receive the best treatment possible for their cancer. There is ongoing research and clinical trials to develop new and effective treatment options for pets with cancer. Many veterinary medical advances have been made in recent years. One breakthrough treatment was the development of the ONCEPT Canine Melanoma Vaccine. ONCEPT Canine Melanoma Vaccine therapeutic vaccine is manufactured by Merial, a world leading, innovation-driven animal health company and the maker of many canine vaccines, including the world's leading rabies vaccines.

Market Dynamics

Increasing adoption of inorganic growth strategies such as partnership by the key players in the market for research and development program and awareness programs for the veterinary oncology treatment is expected to drive the market over the forecast period. For instance, in August 2022, a Siemens Healthineers company, a healthcare company, and the University of Illinois Veterinary Teaching Hospital partnered to provide a 2-day clinical educational program in veterinary radiation oncology. According to a company release, the inaugural clinical 'school,' hosted by Varian Veterinary Oncology, occurred on from August 12 - 13, 2022. Custom designed for the veterinary radiation oncology team, the curriculum will hone in on clinical workflows, clinical implementation, treatment planning, and treatment delivery. Participants will obtain instruction on radiotherapy and similar topics and will participate in hands-on workshops.

Key features of the study:

• This report provides an in-depth analysis of the global veterinary oncology market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global veterinary oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., and Rhizen Pharmaceutical SA.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global veterinary oncology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary oncology market

Detailed Segmentation:

• Global Veterinary Oncology Market, By Animal Type:
  • Companion Animal
    • Equine
    • Canine
    • Feline
  • Livestock Animal
• Global Veterinary Oncology Market, By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
• Global Veterinary Oncology Market, By Mode of Administration:
  • Oral
  • Intravenous
• Global Veterinary Oncology Market, By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
• Global Veterinary Oncology Market, By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
• Global Veterinary Oncology Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Zoetis Inc.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Elanco
  • AB Science
  • Boehringer Ingelheim International GmbH
  • Zenoaq
  • VetDC
  • Morphogenesis, Inc.
  • Karyopharm Therapeutics, Inc.
  • Regeneus Ltd.
  • AdvaVet, Inc.
  • Rhizen Pharmaceutical SA

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Therapy Type
  • Market Snapshot, By Mode of Administration
  • Market Snapshot, By Application
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Initiatives for Prevention and Control of Veterinary Oncology
• Radiation Therapy
• Market Trends
• Product Recall
• Epidemiology
• Key Developments
• Cancers in Cats
• Cancers in Dogs
• Chemotherapy Agents Commonly used in Veterinary Medicine
• Regulatory Scenario
• Veterinary Medicines: Patent Information
• Veterinary Cancer: Awareness Campaign
• Mergers and Acquisitions
• PEST Analysis

4. Global Veterinary Oncology Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Veterinary Oncology Market, By Animal Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Companion Animal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Equine
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Canine
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Feline
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Livestock Animal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Veterinary Oncology Market, By Therapy Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Chemotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Combination Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Immunotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Targeted Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Veterinary Oncology Market, By Mode of Administration, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Intravenous
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Veterinary Oncology Market, By Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Canine Lymphoma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Osteosarcoma (OSA)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Mast Cell Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Melanoma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Multiple Myeloma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Veterinary Oncology Market, By Distribution Channel, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Government Agencies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

10. Global Veterinary Oncology Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

11. Competitive Landscape

• Company Profiles
  • Zoetis Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Elanco
  • AB Science
  • Boehringer Ingelheim International GmbH
  • Zenoaq
  • VetDC
  • Morphogenesis, Inc.
  • Karyopharm Therapeutics, Inc.
  • Regeneus Ltd.
  • AdvaVet, Inc.
  • Rhizen Pharmaceutical SA
• Analyst Views

12. Section

• References
• Research Methodology
• About Us